Data from: effects of phloretin therapy on water and glucose transport during experimental peritoneal dialysis: a dose-response study

Unwanted glucose absorption remains a major drawback of peritoneal
dialysis treatment. Recently we found that phloretin, a non-selective
blocker of faciltative glucose channels (GLUTs), acts to reduce glucose
absorption thereby improving osmotic water removal during peritoneal
dialysis. Experimental peritoneal dialysis was conducted on fifty healthy
Sprague-Dawley rats. The animals were exposed to glucose-based dialysis
fluid containing five different concentrations of phloretin. To determine
the plasma-to-dialysate transport, we used radiolabeled 18F-deoxyglucose.